Integrating network pharmacology and drug side-effect data to explore mechanism of liver injury-induced by tyrosine kinase inhibitors
- 28 January 2024
- journal article
- research article
- Published by Elsevier in Computers in Biology and Medicine
- Vol. 170, 108040
Abstract
No abstract availableKeywords
Funding Information
- National Key Research and Development Program of China
- National Key Research and Development Program of China Stem Cell and Translational Research (2021YFF0702003)
- Sichuan University
- West China Hospital, Sichuan University
This publication has 58 references indexed in Scilit:
- Loss of liver E-cadherin induces sclerosing cholangitis and promotes carcinogenesisProceedings of the National Academy of Sciences, 2014
- Depressing Mitochondria-Reticulum Interactions Protects Cardiomyocytes From Lethal Hypoxia-Reoxygenation InjuryCirculation, 2013
- Hepatotoxicity of Tyrosine Kinase Inhibitors: Clinical and Regulatory PerspectivesDrug Safety, 2013
- Risk of tyrosine kinase inhibitors-induced hepatotoxicity in cancer patients: A meta-analysisCancer Treatment Reviews, 2013
- Fatal Liver Failure in a Patient Treated With Sunitinib for Renal Cell CarcinomaClinical Genitourinary Cancer, 2013
- NCBI GEO: archive for functional genomics data sets—updateNucleic Acids Research, 2012
- Assessment of reactive metabolites in drug-induced liver injuryArchives of Pharmacal Research, 2011
- Tyrosine kinase inhibitors: Multi-targeted or single-targeted?World Journal of Clinical Oncology, 2011
- Mechanism-Based Inactivation of Cytochrome P450 3A4 by LapatinibMolecular Pharmacology, 2010
- NF-κB and JNK: An Intricate AffairCell Cycle, 2004